首页> 美国卫生研究院文献>The British Journal of Ophthalmology >In vitro antibiotic resistance in bacterial keratitis in London
【2h】

In vitro antibiotic resistance in bacterial keratitis in London

机译:伦敦细菌性角膜炎的体外抗生素耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM—To document changes in the profile of bacterial isolates from cases of keratitis and changes in their susceptibility to first line antibiotic therapies.
METHODS—A retrospective review was performed of all bacterial isolates from cases of keratitis seen between 1984 and 1999. In vitro laboratory susceptibilities to antibiotics were determined by the Kirby-Bauer disc diffusion method. The number of isolates, changes in the proportion of bacterial types, and the number that were fully resistant to monotherapy (ofloxacin), dual therapy (gentamicin and cefuroxime), and prophylactic treatment (chloramphenicol) were calculated.
RESULTS—There were 1312 bacterial isolates over 16 years. Gram positive bacteria accounted for 54.7% of isolates and Staphylococcus species (33.4%) were the most frequently isolated organisms. During the study period there has been an increase in the proportion of Pseudomonas species isolates but no overall increase in the proportion of Gram negative isolates. There has not been an increase in the proportion of isolates resistant to ofloxacin since 1995 or an increase in resistance to the combination of gentamicin and cefuroxime. However, since 1984 there has been a significant increase in proportion of Gram negative organisms resistant to chloramphenicol (p=0.0019).
CONCLUSIONS—An increase in the in vitro resistance of organisms to first line therapies for bacterial keratitis has not been observed. An increased resistance to chloramphenicol indicates that this drug is unlikely to provide prophylactic cover when Gram negative infection is a risk. Continued monitoring for the emergence of antibiotic resistance is recommended.

机译:目的—记录角膜炎病例中细菌分离株的概况变化以及对一线抗生素治疗的敏感性变化。
方法—对1984年至1999年间发现的所有角膜炎细菌分离株进行回顾性回顾通过Kirby-Bauer椎间盘扩散法确定体外实验室对抗生素的敏感性。计算了分离株的数量,细菌类型比例的变化以及对单药(氧氟沙星),双重疗法(庆大霉素和头孢呋辛)和预防性治疗(氯霉素)完全耐药的数目。
结果—有超过16年的细菌分离物为1312种。革兰氏阳性菌占分离株的54.7%,葡萄球菌属菌种(33.4%)是最常见的分离菌。在研究期间,假单胞菌种类分离物的比例有所增加,但革兰氏阴性分离物的比例没有整体增加。自1995年起,对氧氟沙星耐药菌株的比例没有增加,对庆大霉素和头孢呋辛组合的耐药性也没有增加。然而,自1984年以来,革兰氏阴性生物对氯霉素的耐药性比例显着增加(p = 0.0019)。
结论—细菌对细菌性角膜炎一线疗法的体外耐药性尚未增加。观测到的。对氯霉素的抵抗力增强表明,当有革兰氏阴性感染风险时,该药物不太可能提供预防性覆盖。建议继续监测抗生素耐药性的出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号